About UPI  |  UPI en Español   |   My Account
Free News Update:
United Press International - News. Analysis. Insight.™ - 100 Years of Journalistic Excellence
  • Home
  • Top News
  • Entertainment
  • Odd News
  • Sports
    • Baseball
    • Football
    • Golf
    • Olympics 2008
    • Tennis
  • Business
  • Science
  • Health
  • Analysis
    • Energy Resources
    • Security Industry
    • Emerging Threats
  • Media
    • Video
    • News Photos
  • Features
    • The Voice of Young Voters
    • Path to the Presidency
    • Energy
    • Beijing Olympics 2008
Search:
Go
Market Summary | Major Indices | Market Movers | Market Sectors | A-Z Stock Listings | Mutual Funds
World Markets | CEO Wealthmeter | Stock Splits | ETF Screener | Oil / Energy | Metals
Bank Rates | Treasury Rates | Currencies | Calculators | My Watchlist | My Portfolio
         Symbol Lookup
APP Pharmaceuticals, Inc. Add to My Watchlist (NSDQ: APPX) 

Detailed Quote
News
Chart
SEC Filings
Profile
Historical
Company Quote
 
Stock Data
Last Price 23.70 (10.01.08 9:00 AM EDT)
Change (%)     - (-)
Volume -
Open -
Previous Close 23.70
Day High 23.70
Day Low 23.70
Bid N/A x 500
Ask N/A x 100
 
Average Volume 180,858
Shares Outstanding 160.79M
Market Cap 3.8B
Year High 24.15
Year Low 9.56
Earnings Per Share 0.38
P/E Ratio 62.4
Dividend N/A
Yield N/A
Chart
Intraday | 3 Month | 6 Month | 1 Year
 
Related Companies
Symbol Last Change (%)
UCBJF 25.75 -4.25 (-14.17%)
RESP 65.96 +0.00 (+0.00)
VAR 39.05 +0.00 (+0.00)
UNCHF 70.55 +0.00 (+0.00)
HLUKF 1.55 +0.00 (+0.00)
ABC 29.45 +0.00 (+0.00)
HSP 29.19 +0.00 (+0.00)
Press Releases: APPX
Wed, Sep 10, 2008
APP Pharmaceuticals Announces Trading Information on NASDAQ of Contingent Value Rights Associated with the Acquisition by Fresenius
- Business Wire
APP Pharmaceuticals Announces Completion of Acquisition by Fresenius
- Business Wire
Wed, Sep 03, 2008
Mergent, Inc. Announces Changes to the HealthShares(TM) Cancer Index, Composite Index, Dermatology and Wound Care Index, Enabling Technologies Index, and Infectious Disease Index
- PR Newswire
Tue, Sep 02, 2008
APP Pharmaceuticals and Fresenius Announce Clearance of APP Acquisition by U.S. Federal Trade Commission
- Business Wire
Mon, Aug 18, 2008
APP Pharmaceuticals Receives Manufacturing Approval for Three Product Codes of Heparin at Puerto Rico Facility
Approvals Significantly Expand Manufacturing Capacity for Heparin
- Business Wire
More Press Releases
News: APPX
Sun, Aug 24, 2008
APP Pharmaceuticals, Inc. Q2 2008 Earnings Call Transcript

APP Pharmaceuticals, Inc. (APPX)

Q2 2008 Earnings Call Transcript


Complete Story »
- Transcripts from See...
Mon, Aug 18, 2008
The Year's Top Stock
You may not get it, but it may not matter.
- Fool.com Headlines
Fri, Aug 01, 2008
APP Pharmaceuticals (APPX) Reports Slightly Higher Q2 Earnings; Issues Soft FY08 Guidance
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=3868023 for the full story.
- StreetInsider
Thu, Jul 10, 2008
Buyout or Sellout?
These seven companies have the urge to merge. Which deals will be the ones to work out?
- Fool.com Headlines
Tue, Jul 08, 2008
Now That's the Way to Spin Off a Company
Sell off the spin-off for more than the company was worth before the breakup.
- Fool.com Headlines
More News
Blogs: APPX
Tue, Aug 05, 2008
Weekly Mergers and Acquisitions Report
APP Pharmaceuticals, Inc. (APPX) - Fresenius, Allied Waste Industries (AW) - Republic Services, Inc. (RSG), Alpha Natural Resources, Inc. (ANR) - Cleveland-Cliffs Inc (CLF)[More...]
- home: iStockAnalyst....
Mon, Jul 07, 2008
Fresenius gets some APP medicine for $3.7 billion

Filed under: Deals

It's been a good year for APP Pharmaceuticals Inc. (NASDAQ: APPX), as the stock price has climbed from $10 to $23.50. Today there was some extra good news: Fresenius SE, the largest intravenous drug developer in Europe, has agreed to shell out $3.7 billion for the company (there will also be $940 million in assumed debt). In today's trading, APP's stock is up 32%.

It's a great day for Soon-Shiong who founded APP in 1996 and still owns a whopping 80% of the company.

APP is a leader in developing generic injectable pharma products, such as for acute care and specialty clinic applications. In the company's latest quarterly report, revenues increased 6% to $148.1 million and adjustable net income was $22 million, or $0.14 per share. What's more, the company received final FDA approval on four products: Polymixin B Sulfate, Caffeine Citrate Oral Solution and Irinotecan Hydrochloride. There was also a product launch for Cefepime Hydrochloride.

However, investors of Fresenius aren't so happy. The company's shares dropped about 10% in Germany. Essentially, there are concerns about valuation as well as the ability to finance the deal, which will involve mostly debt. Yet, if Fresenius wants to enter the U.S. market, it really has no choice but to pay a premium.

Tom Taulli is the author of various books, including The Complete M&A Handbook and The Edgar Online Guide to Decoding Financial Statements. He also operates MergerBook.com.

Permalink | Email this | Comments

- BloggingStocks
Saying a lot in very few words…
Earlier today, Fresenius SE (FRE3:GY) announced that it was buying APP Pharmaceuticals (APPX) for $4.6 billion, or around $23 a share. The deal represented a substantial premium — just shy of 30% — over where APP’s shares closed on Thursday, before the markets closed for the July 4 holiday. But what’s really interesting is this 8K [...]
- footnoted.org
Before the bell: MER, APPX, AAPL, MRK, DIS, NWS

Filed under: Before the bell, Analyst reports, Analyst upgrades and downgrades, Deals, Apple Inc (AAPL), Walt Disney (DIS), Merrill Lynch (MER), Merck and Co (MRK), News Corp'B' (NWS)

Before the bell: Futures mixed as oil drops, ahead of earnings season kickoff

According to the New York Post Friday, Merrill Lynch (NYSE: MER) is in talks to sell its 20% stake in Bloomberg L.P. back to New York City Mayor Michael Bloomberg. The post cited anonymous sources. But Merrill will likely not end its cash raising efforts there and could also try to sell its 49% stake in investment manager BlackRock ( NYSE: BLK). Selling different assets, could bring some $50 billion to cash-strapped Merrill.

APP Pharmaceuticals (NASDAQ: APPX) shares are up nearly 32% to $23.50 in premarket trading after Germany's health-care giant Fresenius said it's going to buy it for up to $4.6 billion, or $29 a share, depending if certain financial targets are met. This marks Fresenius attempt to enter the U.S. market.

Apple Inc. (NASDAQ: AAPL) is set to launch its next generation iPhone Friday. The 3G, or third-generation, phone will be cheaper and faster than its predecessor and could expand Apple's reach to many more countries that rely on that technology. Apple has set a target to sell 10 million iPhones in 2008, and already sold 1.79 million in the first quarter. Analysts have so far kept their target on Apple, such as Lehman reiterating its Overweight on the stock.

Continue reading Before the bell: MER, APPX, AAPL, MRK, DIS, NWS

Permalink | Email this | Comments

- BloggingStocks
Pre-market movers (TWX) (UBS)

Filed under: Before the bell, Time Warner (TWX), Teva Pharm Indus ADR (TEVA)

APP Pharmaceuticals (NASDAQ:APPX) is up over 30% on a buy-out offer from Fresenius.

Time Warner (NYSE:TWX) is up almost 2% after positive comments in Barron's.

Teva Pharmaceutical (NASDAQ:TEVA) is off 6% on news that one of its drug trials went poorly.

UBS (NYSE:UBS) is down over 5% on concerns that the bank will report large write-offs for the last quarter.

Stocks made trade differently in the pre-market than they do in the regular session.

Douglas A. McIntyre is an editor at 247wallst.com.

Permalink | Email this | Comments

- BloggingStocks
More Blogs
Conference Calls for APPX
08/01/08 Q2 2008 Earnings  
Archive for APPX
07/07/08 Business News  
APP Pharmaceuticals to Be Acquired by Fresenius 
Archive for APPX
05/08/08 Q1 2008 Earnings  
Archive for APPX
03/07/08 Q4 2007 Earnings  
Archive for APPX
02/17/06 Q4 2005 Earnings  
Archive for APPX
Powered By: FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes.
NYMEX & COMEX data is delayed at least 30 minutes.
All other data is delayed at least 20 minutes.
By accessing this page, you agree to the following terms and conditions.
Conference calls info supplied by OpenCompany
Fundamental data supplied by Mergent, Inc.
Stock quote data supplied by Telekurs
COMPANY NAME
      5704.13 -105.85 (-1.82% )
  Quote News Chart Profile  
Last: Change: ( %)
Open: Range:  - 
close window
E-mail Article to a Friend




CLOSE WINDOW  
UPI Features - The Voice of Young Voters
Most Popular
Stories
Photos
Videos
People
1.
Eddie Van Halen to wed publicist
2.
Iran recasts report on U.S. jet
3.
Couple told too heavy for plane take off
4.
Melamine found in Cadbury products
5.
Ukraine leader dissolves parliament




Videos
Enlarge Video
Reaction: Does peace have a prize?
Reaction: Does peace have a prize?
Friday, October 10
From Wall Street to a Maryland Main Street
From Wall Street to a Maryland Main Street
Friday, October 10
Debate #2: The economy
Debate #2: The economy
Friday, October 10
Economics vs. foreign policy in the media
Economics vs. foreign policy in the media
Thursday, October 9
© 2008 United Press International, Inc. All Rights Reserved. Official Government Wires  |   About UPI  |   Site Map  |   Terms of Use  |   Privacy Policy  |   Advertise Online  |   Contact Us

Sponsored Links: Fundraisers - Press Release Services - prom dresses - Prom dresses and gowns - Public Records - Wedding and Honeymoon Experts - Auto Dealers - Motivational Sports Speakers Bureau